Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on Energy and Commerce (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : [U.S. Government Publishing Office], [2020]
Series:	Report / 116th Congress, 2d session, House of Representatives ; 116-572
Subjects:	United States. > Food and Drug Administration. Drug development > Economic aspects > United States. Buprenorphine > Therapeutic use > United States. Orphan drugs > Government policy > United States. Drugs > Prices > Government policy > United States. Drugs > Law and legislation > United States. Orphan drugs > United States. Rare diseases > United States. Legislative materials.
Online Access:	https://purl.fdlp.gov/GPO/gpo148015

Available Online